neoplas med GmbH – Trademark Portfolio

Entity Type: 16

neoplas med GmbH holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include NEOPLAS MED and NEOPLAS MED ADVANCED COLD PLASMA THERAPY.

Walther-Rathenau-Str. 49a

17489 Greifswald

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

neoplas med GmbH's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does neoplas med GmbH have?

neoplas med GmbH has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does neoplas med GmbH file in?

neoplas med GmbH files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are neoplas med GmbH's most well-known trademarks?

neoplas med GmbH's registered trademark portfolio includes well-known marks such as NEOPLAS MED and NEOPLAS MED ADVANCED COLD PLASMA THERAPY. These are among 2 currently registered trademarks in the portfolio.

What is neoplas med GmbH's trademark registration success rate?

neoplas med GmbH has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.